Matches in Wikidata for { <http://www.wikidata.org/entity/Q38021953> ?p ?o ?g. }
- Q38021953 description "article científic" @default.
- Q38021953 description "article scientifique" @default.
- Q38021953 description "articol științific" @default.
- Q38021953 description "articolo scientifico" @default.
- Q38021953 description "artigo científico" @default.
- Q38021953 description "artigo científico" @default.
- Q38021953 description "artigo científico" @default.
- Q38021953 description "artikel ilmiah" @default.
- Q38021953 description "artikull shkencor" @default.
- Q38021953 description "artículo científico" @default.
- Q38021953 description "artículu científicu espublizáu en 2012" @default.
- Q38021953 description "bilimsel makale" @default.
- Q38021953 description "scienca artikolo" @default.
- Q38021953 description "scientific article published on 27 June 2012" @default.
- Q38021953 description "scientific article published on 27 June 2012" @default.
- Q38021953 description "scientific article published on 27 June 2012" @default.
- Q38021953 description "vedecký článok" @default.
- Q38021953 description "vetenskaplig artikel" @default.
- Q38021953 description "videnskabelig artikel" @default.
- Q38021953 description "vitenskapelig artikkel" @default.
- Q38021953 description "vitskapeleg artikkel" @default.
- Q38021953 description "vědecký článek" @default.
- Q38021953 description "wetenschappelijk artikel" @default.
- Q38021953 description "wissenschaftlicher Artikel" @default.
- Q38021953 description "наукова стаття, опублікована в червні 2012" @default.
- Q38021953 description "научная статья" @default.
- Q38021953 description "научни чланак" @default.
- Q38021953 description "מאמר מדעי" @default.
- Q38021953 description "مقالة علمية نشرت في 27 يونيو 2012" @default.
- Q38021953 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38021953 name "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 name "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 name "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 type Item @default.
- Q38021953 label "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 label "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 label "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 prefLabel "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 prefLabel "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 prefLabel "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 P1433 Q38021953-B90C56F1-39C0-43E6-A13D-0F3D4781996C @default.
- Q38021953 P1476 Q38021953-C4337DE3-05EC-4144-90EE-C6DEAA97F506 @default.
- Q38021953 P2093 Q38021953-23A3FA1C-7263-47B6-8967-AD54C70C9D0D @default.
- Q38021953 P2093 Q38021953-5E331DAA-47FA-442E-AB88-351513B317CC @default.
- Q38021953 P2860 Q38021953-1BF78F6E-7C0B-4F29-88A2-D44B8736CE37 @default.
- Q38021953 P2860 Q38021953-1EF3BAA3-A39A-490D-9B77-C17AED88AF00 @default.
- Q38021953 P2860 Q38021953-24813FCB-540D-4A95-8BC3-368C5E6E4673 @default.
- Q38021953 P2860 Q38021953-39DF4BB3-C65C-4B89-934C-9160FD742804 @default.
- Q38021953 P2860 Q38021953-424D3A8E-3D91-4E14-8B12-B28B86975B1F @default.
- Q38021953 P2860 Q38021953-5194F802-7EB5-4931-AD54-37813F2B8484 @default.
- Q38021953 P2860 Q38021953-51AFC660-E550-49DA-AD14-E733B0A150EE @default.
- Q38021953 P2860 Q38021953-5825695A-7C8B-49D9-AB56-D0AE66A97B5C @default.
- Q38021953 P2860 Q38021953-5B4B21B7-844A-42BF-81C4-6A5A80531589 @default.
- Q38021953 P2860 Q38021953-5BDD66D8-C621-4287-ADE7-8B46E3CE2B87 @default.
- Q38021953 P2860 Q38021953-61037FCC-4ADC-4507-B3C1-DF2B5946493E @default.
- Q38021953 P2860 Q38021953-650ED821-20F9-4B1A-8EFB-77DA76FDF76B @default.
- Q38021953 P2860 Q38021953-67617E83-DEB2-405E-B1BF-F05CC098BEDD @default.
- Q38021953 P2860 Q38021953-790F24B4-1399-4D45-AEEE-C12C1CE836CC @default.
- Q38021953 P2860 Q38021953-85F2C40E-DF0D-40B1-8EE7-7F8F31A5763A @default.
- Q38021953 P2860 Q38021953-929D7F77-B1EE-4CB1-AD1F-8847E25D2B5C @default.
- Q38021953 P2860 Q38021953-B0874C19-6BF1-489E-BEA6-8E794FD135B9 @default.
- Q38021953 P2860 Q38021953-B13E440A-19CE-450C-8B87-839C077360DC @default.
- Q38021953 P2860 Q38021953-B95E87FA-B56B-4599-B1C9-8AA41439730E @default.
- Q38021953 P2860 Q38021953-BDFDC05E-8816-418E-8755-172E455F662E @default.
- Q38021953 P2860 Q38021953-C2BF6260-BCCD-4FE3-81A6-7B73AB2540E0 @default.
- Q38021953 P2860 Q38021953-CCF2E113-B47B-4703-B283-5476659B8C60 @default.
- Q38021953 P2860 Q38021953-D27FA2DA-FE50-472E-8314-B45518F93CA8 @default.
- Q38021953 P2860 Q38021953-E19192AF-5F02-4E89-9ED5-985CE0454D49 @default.
- Q38021953 P2860 Q38021953-F2DF8863-F6ED-4D99-9C61-6C4114B2B054 @default.
- Q38021953 P2860 Q38021953-FF4AC138-A80A-4A15-B137-680E0FC0F581 @default.
- Q38021953 P2888 Q38021953-769FD743-529D-49C6-BA21-77CC419F8524 @default.
- Q38021953 P304 Q38021953-5681ABC6-251A-4095-8274-7D4AD9C6F85C @default.
- Q38021953 P31 Q38021953-3C9394BC-0140-4988-AE15-7D55A6C0E85B @default.
- Q38021953 P356 Q38021953-3FBC85CD-2731-4B7E-B728-3D9B9359082D @default.
- Q38021953 P407 Q38021953-69ADAFD4-B7B0-4A17-8D58-B56F3C4D6F8E @default.
- Q38021953 P433 Q38021953-697CA7F3-F789-428F-8971-D49BEF11A859 @default.
- Q38021953 P478 Q38021953-C19FDA36-5F89-4F15-B87C-17AD12CAE09F @default.
- Q38021953 P577 Q38021953-864ADC8E-D424-4901-8158-CD1ABD933741 @default.
- Q38021953 P5875 Q38021953-63C84B1F-007C-4062-9280-6F81B9B825E0 @default.
- Q38021953 P6179 Q38021953-59DC7EA8-D399-476B-B6C9-33C395530F70 @default.
- Q38021953 P698 Q38021953-AA4086C7-8420-47FD-AD1A-102526E838E4 @default.
- Q38021953 P932 Q38021953-31DF733E-599A-4CBD-8B7D-76A5F16C4EFE @default.
- Q38021953 P356 S12248-012-9383-0 @default.
- Q38021953 P698 22736294 @default.
- Q38021953 P1433 Q10695361 @default.
- Q38021953 P1476 "Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds" @default.
- Q38021953 P2093 "Amitava Mitra" @default.
- Q38021953 P2093 "Filippos Kesisoglou" @default.
- Q38021953 P2860 Q30903645 @default.
- Q38021953 P2860 Q33425774 @default.
- Q38021953 P2860 Q34190317 @default.
- Q38021953 P2860 Q35069024 @default.
- Q38021953 P2860 Q36865278 @default.
- Q38021953 P2860 Q37109079 @default.
- Q38021953 P2860 Q37249988 @default.
- Q38021953 P2860 Q37776880 @default.
- Q38021953 P2860 Q37827612 @default.
- Q38021953 P2860 Q39418393 @default.
- Q38021953 P2860 Q39860380 @default.
- Q38021953 P2860 Q39902924 @default.